STOCK TITAN

Cohen & Steers (CNS) director reports 436-share RSU-based stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, increasing their holdings to 23,591 shares held directly.

The filing explains that these 436 shares reflect common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares are scheduled to be delivered to the director on the third anniversary of the grant date. This is a routine insider compensation transaction rather than an open-market stock purchase.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Connor Frank T

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 A 436(1) A $0 23,591 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cohen & Steers (CNS) disclose in this Form 4?

The company disclosed that a director acquired 436 shares of Cohen & Steers common stock on 01/02/2026, reported as an acquisition at a price of $0.

How many Cohen & Steers (CNS) shares does the reporting person own after this transaction?

Following the reported grant, the director beneficially owns 23,591 shares of Cohen & Steers common stock, held in direct ownership.

What is the nature of the 436 Cohen & Steers (CNS) shares reported in the filing?

The 436 shares represent common stock underlying restricted stock units granted by Cohen & Steers. These restricted stock units were 100% vested on the grant date.

When will the restricted stock unit shares for Cohen & Steers (CNS) be delivered?

The filing states that the shares related to the restricted stock units will be delivered on the third anniversary of the grant date of 01/02/2026.

Is the reported Cohen & Steers (CNS) transaction an open-market purchase?

No. The 436 shares were acquired at $0 as part of an equity compensation grant of restricted stock units, rather than an open-market purchase.

What role does the reporting person have at Cohen & Steers (CNS)?

The reporting person is identified as a director of Cohen & Steers, Inc., and the Form 4 is filed as a single reporting person.

Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.47B
27.29M
46.02%
60.33%
3.88%
Asset Management
Investment Advice
Link
United States
NEW YORK